Key result
Cardiac troponin I autoantibody (cTnIAAb) binds to cardiomyocyte membrane α-Enolase (ENO1) and triggers cell apoptosis via the PTEN-Akt signaling axis, leading to impaired systolic dysfunction.
Why the study?
The molecular mechanisms underlying cardiac troponin I autoantibody binding to cardiomyocytes and resultant myocardial damage or dysfunction were unknown.
Answers are grounded in this paper and cite their sources.
Cardiac troponin I autoantibodies contribute to ventricular remodeling and myocardial dysfunction after injury via the ENO1-PTEN-Akt signaling axis.
BACKGROUND: The objective of the current study was to study the molecular mechanism(s) underlying cardiac troponin I autoantibody (cTnIAAb) binding to cardiomyocyte and resultant myocardial damage/dysfunction. METHODS: cTnIAAb was purified from serum of 10 acute myocardial infarction (AMI) patients with left ventricular remodeling. Recombinant human cTnI was used to generate three mouse-derived monoclonal anti-cTnI antibodies (cTnImAb1, cTnImAb2, and cTnImAb3). The target proteins in cardiac myocyte membrane bound to cTnImAb and effect of cTnIAAb and cTnImAb on apoptosis and myocardial function were determined. FINDINGS: We found that cTnIAAb/cTnImAb1 directly bound to the cardiomyocyte membraneα-Enolase (ENO1) and triggered cell apoptosis via increased expression of ENO1 and Bax, decreased expression of Bcl2, subsequently activating Caspase8, Caspase 3, phosphatase and tensin homolog (PTEN) while inhibiting Akt activity. This cTnIAAb-ENO1-PTEN-Akt signaling axis contributed to increased myocardial apoptosis, myocardial collagen deposition, and impaired systolic dysfunction. INTERPRETATION: Results obtained in this study indicate that cTnIAAb is involved in the process of ventricular remodeling after myocardial injury. FUND: The National Natural Science Foundation of China (Grant#: 81260026).
No takes yet. Share an insight, caveat, or question.
Wu et al. (2019) studied Acute myocardial infarction with left ventricular remodeling (n=10). Cardiac troponin I autoantibody (cTnIAAb) was evaluated on Target proteins in cardiac myocyte membrane bound to cTnImAb and effect on apoptosis and myocardial function. Cardiac troponin I autoantibody (cTnIAAb) binds to cardiomyocyte membrane α-Enolase (ENO1) and triggers cell apoptosis via the PTEN-Akt signaling axis, leading to impaired systolic dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: